KSHV infection of human tonsillar B cells

KSHV 感染人扁桃体 B 细胞

基本信息

  • 批准号:
    8606916
  • 负责人:
  • 金额:
    $ 0.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2011
  • 资助国家:
    美国
  • 起止时间:
    2011-12-01 至 2013-11-30
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Kaposi's sarcoma-associated herpesvirus (KSHV), also known as human herpesvirus 8 (HHV8) establishes lifelong infection and is the etiologic agent underlying primary effusion lymphoma, multicentric Castleman's disease, and Kaposi's sarcoma, an endothelial cell-based angiogenic tumor that remains the most prevalent AIDS-associated malignancy worldwide. Although the site for a definitive latent reservoir(s) remains unclear, KSHV can infect B cells in the oral cavity and express a number of viral proteins capable of modulating B cell signaling and survival. Shedding of KSHV in the saliva is frequent in infected individuals and concentrations are often higher than in the peripheral blood. Further, epidemiologic work implicates saliva as a major source for person-to-person viral transmission with infected tonsillar B cells also providing a potential source of spread to distal sites within individuals. In contrast, KSHV-infected B cells in the peripheral circulation are extremely rare in asymptomatic individuals and only slightly less infrequent in patients with early stages of disease. These observations suggest that KSHV may preferentially infect a subset of B cells present in the lymphatic organs of the oral cavity. Our overarching hypothesis is that oral exposure to KSHV leads to selective infection of a specific subset of human tonsillar B cells, effecting phenotypic and functional changes favorable to viral persistence and predictive of pathologic potential. Very little is known about the critical identity and character of KSHV-susceptible B cells in the oral cavity, the nature of the infection, the mechanism underlying differential tropism, or the characteristics of KSHV-induced changes in B cell phenotype and function. We propose to answer these questions. It is our long-term goal to causally link these changes with the expression of specific viral genes and identify those alterations potentially responsible for initiating and sustaining KSHV pathogenesis.)
描述(由申请方提供):卡波西肉瘤相关疱疹病毒(KSHV),也称为人类疱疹病毒8(HHV 8),可造成终身感染,是原发性渗出性淋巴瘤、多中心Castleman病和卡波西肉瘤(一种基于内皮细胞的血管生成肿瘤,仍是全球最常见的艾滋病相关恶性肿瘤)的潜在病原体。尽管确定的潜伏性储库的位点仍不清楚,但KSHV可感染口腔中的B细胞并表达许多能够调节B细胞信号传导和存活的病毒蛋白。KSHV在唾液中的脱落在受感染的个体中是频繁的,并且浓度通常高于外周血。此外,流行病学研究表明,唾液是人与人之间病毒传播的主要来源,受感染的扁桃体B细胞也是传播到个体远端部位的潜在来源。相比之下,KSHV感染的B细胞在外周循环中是非常罕见的, 无症状的个体,在疾病的早期阶段的患者中仅稍微不常见。这些观察结果表明,KSHV可能优先感染口腔淋巴器官中存在的B细胞亚群。我们的总体假设是,口服暴露于KSHV导致选择性感染的人扁桃体B细胞的一个特定的子集,影响表型和功能的变化,有利于病毒的持久性和预测的病理潜力。关于口腔中KSHV易感B细胞的关键特性和特征、感染的性质、差异向性的潜在机制或KSHV诱导的B细胞表型和功能变化的特征知之甚少。我们建议回答这些问题。我们的长期目标是将这些变化与特定病毒基因的表达因果联系起来,并确定那些可能引发和维持KSHV发病机制的改变。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Dean H Kedes其他文献

Dean H Kedes的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Dean H Kedes', 18)}}的其他基金

KSHV infection of human tonsillar B cells
KSHV 感染人扁桃体 B 细胞
  • 批准号:
    8263135
  • 财政年份:
    2011
  • 资助金额:
    $ 0.45万
  • 项目类别:
14th International Workshop on Kaposi's Sarcoma-Associated Herpesvirus and Relate
第14届卡波西肉瘤相关疱疹病毒及相关国际研讨会
  • 批准号:
    8204160
  • 财政年份:
    2011
  • 资助金额:
    $ 0.45万
  • 项目类别:
KSHV infection of human tonsillar B cells
KSHV 感染人扁桃体 B 细胞
  • 批准号:
    8385528
  • 财政年份:
    2011
  • 资助金额:
    $ 0.45万
  • 项目类别:
KSHV infection of human tonsillar B cells
KSHV 感染人扁桃体 B 细胞
  • 批准号:
    8595175
  • 财政年份:
    2011
  • 资助金额:
    $ 0.45万
  • 项目类别:
Luciferase-encoded influenza viruses for antiviral screening
用于抗病毒筛选的荧光素酶编码流感病毒
  • 批准号:
    7153156
  • 财政年份:
    2006
  • 资助金额:
    $ 0.45万
  • 项目类别:
Structure and Molecular Composition of KSHV an RRV
KSHV 和 RRV 的结构和分子组成
  • 批准号:
    7287578
  • 财政年份:
    2000
  • 资助金额:
    $ 0.45万
  • 项目类别:
Structure and Molecular Composition of KSHV an RRV
KSHV 和 RRV 的结构和分子组成
  • 批准号:
    7468626
  • 财政年份:
    2000
  • 资助金额:
    $ 0.45万
  • 项目类别:
Structure and Molecular Composition of KSHV and RRV
KSHV 和 RRV 的结构和分子组成
  • 批准号:
    7064312
  • 财政年份:
    2000
  • 资助金额:
    $ 0.45万
  • 项目类别:
Structure and Molecular Composition of KSHV an RRV
KSHV 和 RRV 的结构和分子组成
  • 批准号:
    7882733
  • 财政年份:
    2000
  • 资助金额:
    $ 0.45万
  • 项目类别:
CAPSID STRUCTURE AND ASSEMBLY IN KSHV
KSHV 中的衣壳结构和组装
  • 批准号:
    6378186
  • 财政年份:
    2000
  • 资助金额:
    $ 0.45万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 0.45万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 0.45万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 0.45万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了